---
type: Phase Execution Record
title: TreatFlow 000-A — Project Intake Start Gate
description: Product-specific intake start gate, evidence posture, workstreams, knowledge ownership, and authorization.
tags: [treatflow, phase-000, start-gate, intake]
---

# TreatFlow — 000-A Project Intake Start Gate

## Decision

**READY TO BEGIN PHASE 000 SUBPHASES.** This is authorization for intake design work only, not Phase 000 closure, architecture selection, or implementation.

## 1. Neutral project statement and provenance

**Stakeholder assertion (project sponsor, initial conversation):** TreatFlow is a contemplated public-facing web application and/or app enabling people to self-report trick-or-treater activity, with geographic descriptors such as state, metro area, and urban/suburban/rural setting. Contributors should be distinguishable through simple, secure authentication or unique identity. Collected observations are intended to support downloadable research datasets and exploratory statistical analysis, including investigation of whether arrivals behave like a Poisson process. Access to data must not compromise contributor security or privacy.

**Observation:** The repository was initialized from the Base concept-design template; no TreatFlow product-specific concept-design closure has occurred. The inherited template's refined phases and historical Base Phase 012 execution are **not TreatFlow phase completion evidence**.

**Hypothesis, not a requirement or scientific conclusion:** Trick-or-treater arrival events may be reasonably characterized by a Poisson model under some conditions. Alternative patterns, changing rates, dependence among arrivals, group arrivals, and reporting bias remain possible.

**Proposals, not fixed design decisions:** web versus native app; specific authentication mechanism; public export formats; geographical granularity; event-logging controls; statistical visualizations; specific storage and deployment technologies. Any current example is context for later discovery.

## 2. Intake evidence posture

Source available: sponsor's initial product premise and the repository's Base methodology. The sponsor's statements establish project intent, not observed demand, security compliance, scientific validity, or a verified user workflow. No field observations, participant interviews, external research, legal assessment, or prior TreatFlow data are presently documented. Treat unknowns as unknowns; do not imply legal or statistical validation. Any later external evidence must be attributed and scoped.

## 3. Required coverage assessment

| Dimension | Disposition | Rationale / next work |
|---|---|---|
| Contemplated product | Adequate for gate | Crowdsourced Halloween arrival reporting and dataset access |
| Opportunity/context | Adequate for gate; refine | Fun, shared observational research opportunity |
| Actors and affected parties | Needs work | Contributors, researchers/downloaders, operators, bystanders, potentially minors |
| Desired outcomes | Adequate for gate; refine | Useful data for exploratory analysis without unsafe disclosure |
| Scope and non-goals | Needs work | MVP boundaries, geographic coverage, platform expectations, public vs private uses |
| Terminology | Needs work | Arrival, visitor, group, observation, session, count, non-observation |
| External constraints | Needs work | Privacy, retention, consent, minors, and applicable obligations require qualification |
| Assumptions and hypotheses | Needs work | Reporting accuracy, Poisson suitability, expected participation, sampling bias |
| Open questions | Needs work | Time resolution, identity, edits, location specificity, export eligibility |
| Evidence/source posture | Adequate for gate; refine | Sponsor assertion identified; no independent validation asserted |
| Legacy/current-state context | Not applicable to product; inherited template review required | No incumbent TreatFlow app identified; Base template is methodology, not product authority |

## 4. Inherited-structure and solution-lock risks

- Base README, knowledge bundle, agents, and phase labels still describe a reusable template, not executed TreatFlow work. Distinguish template contracts/history from product-specific conclusions; correct current orientation during intake rather than retrospectively rewriting template evidence.
- Avoid turning 'secure authentication' directly into a particular identity provider or making an account identifier available in public exports.
- Avoid assuming timestamped clicks equal actual independent arrival events; groups, delayed reporting, intervals without observations, and missingness are substantive research concerns.
- Avoid treating state/metro/context descriptors as automatically safe: combinations with fine timestamps or sparse reports may re-identify a household.
- Do not treat a proposed Poisson distribution as established, or optimize data capture to confirm it.
- Keep the methodology proportionate; no one-document-per-coverage-row requirement.

## 5. Approved sequence and dependencies

### 000-B — Product Context, Actors and Intended Outcomes
Purpose: articulate the motivating opportunity, reporting and analysis participants, affected nonparticipants, candidate outcomes, and relevant participation contexts.
Inputs: this record, sponsor premise, [Phase 000 definition](phase-definition.md), [intake evidence contract](intake-knowledge-contract.md).
Questions: who reports, who consumes data, who is affected, and what meaningful outcome is sought?
Completion evidence: actor/context map, stated outcomes differentiated from assumed demand, explicit uncertainties.
Canonical destination: compact `docs/canonical/project/` current intake owner (create only when warranted); navigation via canonical index.
Excludes: user roles/permissions design and app interaction specification.
Handoff: actor/goal context into 000-C.

### 000-C — Observation Context, Research Hypotheses and Data Sensitivities
Purpose: clarify domain distinctions and research motivation without choosing a data schema.
Inputs: 000-B, sponsor premise, intake contract.
Questions: individual versus group arrivals; observed arrival versus recalled totals; observed duration versus zero counts versus missing reports; local clocks and timezones; changing rates; geographic descriptors; potential bias and privacy exposure.
Completion evidence: domain glossary, testable hypotheses versus assumptions, observation-quality uncertainties, preliminary sensitivity assessment.
Canonical destination: refine the same project owner unless a distinct natural terminology or constraint owner proves necessary.
Excludes: database models, UI controls, statistical-method selection as a feature lock.
Handoff: domain and sensitivity context into 000-D.

### 000-D — Scope, Constraints, Assumptions and Open-Question Disposition
Purpose: set project boundary and credible operating constraints while preserving unresolved decisions for concept discovery.
Inputs: 000-B/C, current relevant methodology and evidence.
Questions: intended initial audience/coverage, participation and availability, explicit non-goals, expected confidentiality, downloads, participant control, applicable privacy/consent questions, and empirical assumptions.
Completion evidence: bounded scope/non-goals, constraints labeled by evidence status, unresolved questions assigned to later phases or risk review.
Canonical destination: same compact project owner with links to phase evidence.
Excludes: auth framework, hosting, schema, exact access-control implementation and final concept catalog.
Handoff: coherent intake dossier to 000-E.

### 000-E — Consolidation, Integrity Audit, Exit Review and Phase 001 Handoff
Purpose: test all Phase 000 coverage against the [exit-review template](exit-review-template.md).
Inputs: completed 000-B through 000-D and governing documentation/knowledge contracts.
Completion evidence: traceable provenance, current canonical ownership and navigation, no duplicated active authority, working relative links, explicit uncertainty, no solution lock, and documented PASS / PASS WITH CARRY-FORWARD / NOT READY TO EXIT with Phase 001 handoff.
Excludes: Phase 001 purpose discovery and all executable implementation.
No Phase 000 closure is claimed by this start gate.

**Dependency:** B establishes users/context; C analyzes domain and data implications without premature structural design; D bounds the project using B/C; E audits the result.

## 6. Knowledge authority and document-change plan

Keep existing Base methodology and phase templates as governing process contracts; do not falsely label template development as TreatFlow progress. This file is chronological phase evidence, not the canonical definition. During B–D, create the smallest meaningful `docs/canonical/project/` current intake owner and link it from `docs/canonical/index.md`, `docs/index.md`, and appropriate phase navigation. Update README / agent orientation to TreatFlow through a scoped, reviewed change, preserving references to inherited Base process rules. Do not copy the whole methodology into new project documents. New ordinary knowledge documents require valid OKF `type` frontmatter; `index.md` remains navigation. Check affected paths, links, supersession, and terminology at every handoff.

## 7. Open questions carried forward

- Is the first release web-only, and who is the initial participant population?
- Are arrivals individual events, groups with sizes, periodic tallies, or multiple permitted observation styles?
- How are start/end observation windows, pauses, unobserved periods, and timezone correctness established?
- Which geography is useful to analysis yet avoids household identification, especially in sparse areas?
- Does the initial dataset require anonymous public access or authenticated access, and at which aggregation level?
- What correction, duplicate, spam, retention, withdrawal, and identity-separation expectations apply?
- What evidence and methods would challenge, rather than merely confirm, a Poisson hypothesis?
- Will children be represented only as counted visitors, rather than contributing account holders?

These are **not blockers to 000-A**; B–D must resolve or responsibly carry them.

## 8. Implementation boundary and verification

- Implementation readiness: **not ready**
- Implementation execution: **not started**
- Implementation authorization: **not yet**
- Phase 000: **in progress, 000-A passed; 000-B next eligible**
- Phase 001: **not authorized yet**

Gate checklist: product premise attributable; all coverage dimensions assessed; dependence-safe subphases B–E defined; current/historical authority distinguished; canonical/index change plan stated; hypothesis, privacy and scientific uncertainty preserved; no code, infrastructure, schema or feature implementation authorized.

**Outcome: READY TO BEGIN PHASE 000 SUBPHASES.**
